Pulmonary artery denervation to treat pulmonary arterial hypertension: The single-center, prospective, first-in-man padn-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)

Journal of the American College of Cardiology

Volumn 62, Issue 12, 2013, Pages 1092-1100

  Chen, Shao Liang ^a,b   Zhang, Feng Fu ^a   Xu, Jing ^a   Xie, Du Jiang ^a   Zhou, Ling ^a   Nguyen, Thach ^c   Stone, Gregg W ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Nanjing Heart Center   (China)

^c St Mary Medical Center   (United States)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

6 min walk test; denervation; pulmonary artery hypertension; pulmonary artery pressure

Indexed keywords

BERAPROST; BOSENTAN; DIGOXIN; HYDROCHLOROTHIAZIDE; SILDENAFIL; SPIRONOLACTONE;

6-MIN WALK TEST; ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENERVATION; DIAGNOSTIC TEST; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MALE; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY ARTERY DENERVATION; PULMONARY HYPERTENSION; SWAN GANZ CATHETER; TREATMENT RESPONSE; TRICUSPID EXCURSION INDEX;

6-MIN WALK TEST; 6MWT; CARDIAC OUTPUT; CO; DENERVATION; IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION; IPAH; MAIN PULMONARY ARTERY; MPA; N-TERMINAL BRAIN NATRIURETIC PEPTIDE; NT-BNP; PA; PADN; PAH; PAOP; PAP; PULMONARY ARTERY; PULMONARY ARTERY DENERVATION; PULMONARY ARTERY HYPERTENSION; PULMONARY ARTERY OCCLUSIVE PRESSURE; PULMONARY ARTERY PRESSURE; PULMONARY VASCULAR RESISTANCE; PVR; RA; RIGHT ATRIUM/ATRIAL; RIGHT VENTRICLE/VENTRICULAR; RV; TEI; TPG; TRANSPULMONARY PRESSURE GRADIENT; TRICUSPID EXCURSION INDEX;

ADULT; CARDIAC CATHETERIZATION; ECHOCARDIOGRAPHY; ENDOVASCULAR PROCEDURES; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PRESSORECEPTORS; PROSPECTIVE STUDIES; PULMONARY ARTERY; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84883753645     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.05.075     Document Type: Article

References (35)

1. L.J. Rubin Primary pulmonary hypertension N Engl J Med 336 1997 111 117
2. N. Galie, A. Manes, and L. Negro A meta-analysis of randomized controlled trials in pulmonary arterial hypertension Eur Heart J 30 2009 394 403
3. M.M. Hoeper, J.A. Barberia, and R.N. Channick Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension J Am Coll Cardiol 54 2009 S85 S96
4. J. Osorio, and M. Russek Reflex changes on the pulmonary and systemic pressures elicited by stimulation of baroreceptors in the pulmonary artery Circ Res 10 1962 664 667
5. C.E. Juratsch, J.A. Jengo, J. Castagna, and M.M. Laks Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature Chest 77 1980 525 530
6. B.G. Baylen, G.C. Emmanouilides, C.E. Juratsch, and Y. Yoshida Main pulmonary artery distention: a potential mechanism for acute pulmonary hypertension in the human newborn infant J Pediatr 96 1980 540 544
7. S.L. Chen, Y.J. Zhang, and L. Zhou Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo EuroIntervention 9 2013 269 276
8. A.R. Tonelli, K.K. Mubarak, and S.C. Mathai Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension Respir Med 104 2010 481 496
9. D.B. Badesch, H.C. Champion, and M.A. Sanchez Diagnosis and assessment of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S55 S66
10. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 1982 377 381
11. L.J. Rubin American College of Chest Physicians Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines Chest 126 Suppl 2004 7S 10S
12. R.M. Lang, M. Bierig, and R.B. Deverus Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group J Am Soc Echocardiogr 18 2005 1440 1463
13. S.R. Ommen, R.A. Nishimura, D.G. Hurrell, and K.W. Klarich Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and cardiographic study Mayo Clin Proc 75 2000 24 29
14. C. Tei, R.A. Nishmura, J.B. Seward, and A.J. Tajik Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurement of cardiac catheterization measurements J Am Soc Echocardiogr 10 1997 169 178
15. N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Eur Heart J 30 2009 2493 2537
16. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT) N. Galie, M.M. Hoeper, and M. Humbert Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Respir J 34 2009 1219 1263
17. A.R. Tonelli, K.K. Mubarak, and N. Li Effect of balloon inflation volume on pulmonary artery occlusion pressure in patients with and without pulmonary hypertension Chest 139 2011 115 121
18. J.R. Anderson, and J.J. Nawarskas Pharmacotherapeutic management of pulmonary arterial hypertension Cardiol Rev 18 2010 148 162
19. S. Rich The value of approved therapies for pulmonary arterial hypertension Am Heart J 153 2007 889 890
20. H.W. Farber The status of pulmonary arterial hypertension in 2008 Circulation 117 2008 2966 2968
21. H.A. Ghofrani, M.W. Wilkins, and S. Rich Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension Circulation 118 2008 1195 1201
22. R. Rushmer Cardiac Diagnosis: Physiological Approach 1955 W. B. Saunders Co Philadelphia, PA 49
23. J.C. Coleridge, and C. Kidd Electrophysiological evidences of baroreceptors in the pulmonary artery of the dog J Physiol 150 1960 319 323
24. T. Haneda, T. Nakajima, and K. Shirato Effects of oxygen breathing on pulmonary vascular input impedance in patients with pulmonary hypertension Chest 83 1983 520 527
25. N. Nagaya, T. Nishikimi, and M. Uematsu Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension Circulation 102 2000 865 870
26. A.M. Richards, H. Ikram, and I.G. Crozier Ambulatory pulmonary arterial pressure in primary pulmonary hypertension: variability, relation to systemic arterial pressure, and plasma catecholamines Br Heart J 63 1990 103 108
27. M. Nootens, E. Kaufmann, and T. Rector Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels J Am Coll Cardiol 26 1995 1581 1585
28. M.R. Bristow, W. Minobe, and R. Rasmussen β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms J Clin Invest 89 1992 803 815
29. S. Velez-Roa, A. Ciarka, and B. Najem Increased sympathetic nerve activity in pulmonary artery hypertension Circulation 110 2004 1308 1312
30. R. Wensel, C. Jilek, and M. Dorr Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension Eur Respir J 34 2009 895 901
31. M.C. Esler, H. Krum, and P.A. Sobotka Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 trial): a randomized control trial Lancet 376 2012 1903 1909
32. H.H. Leuchte, M. El Nounou, and J.C. Tuerpe N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension Chest 131 2007 402 409
33. A. Fijalkowska, M. Kurzyna, and A. Torbicki Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension Chest 129 2006 1313 1321
34. R.P. Frantz, I.M. Robbins, and L.A. Durst Endothelin-1 and BNP plasma levels predict survival in patients with pulmonary arterial hypertension Am J Respir Crit Care Med 177 2008 A535
35. N. Galiè, M. Palazzini, E. Leci, and A. Manes Current therapeutic approaches to pulmonary arterial hypertension Rev Esp Cardiol 63 2010 708 724